AFJK — Aimei Health Technology Co Income Statement
0.000.00%
Last trade - 00:00- $69.79m
- $70.99m
- 21
- 43
- 31
- 21
Annual income statement for Aimei Health Technology Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Total Revenue | 0 | 0 |
| Other Operating Expenses | ||
| Total Operating Expenses | 0.028 | 1.06 |
| Operating Profit | -0.028 | -1.06 |
| Total Net Non Operating Interest Income / Expense | ||
| Net Income Before Taxes | 0.171 | 2.55 |
| Net Income After Taxes | 0.171 | 2.55 |
| Net Income Before Extraordinary Items | ||
| Net Income | 0.171 | 2.55 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 0.171 | 2.55 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 0.019 | 0.283 |